Clinical Trials for Medpace

Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Study of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

Azeliragon in MGMT Unmethylated Glioblastoma

Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies

Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)

Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction

Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic Disease

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects